首页> 外文会议>World biomaterials congress >Bone augmentation in sinus floor elevation by octacalcium phosphate collagen composite
【24h】

Bone augmentation in sinus floor elevation by octacalcium phosphate collagen composite

机译:乳酸胶乳胶原复合材料中鼻窦地板抬高的骨增强

获取原文

摘要

Introduction: Synthetic octacalcium phosphate (OCP) has become recognized as a highly osteoconductive bone substitute material based on in vitro and vivo studies . OCP enhances osteoblastic cell differentiation in vitro in a dose-dependent manner . Furthermore, the dose-dependent stimulatory capacity of OCP was confirmed in vivo implantation with collagen matrix in rat critical sized calvaria defect W. OCP has higher solubility than be-ta tricalcium phosphate (be-ta TCP) therefore more resorbable than beta TCP in vivo . It has been shown that OCP combined with collagen (OCP/Collagen) facilitates bone regeneration in comparison with OCP itself . The osteoconductivity of OCP/Collagen has been demonstrated also in critical-sized bone defect of dog . After that, we examined the effect of OCP/Collagen on bone regeneration in human small bone defect and confirmed the healing at the defect. In this study, we performed sinus floor elevation for bone augmentation by OCP/Collagen as a preparation for dental implant treatment in clinical patient. Experimental methods: OCP was prepared according to a method of synthesis by mixing calcium nad phosphate solution . Particle size of OCP was 300 - 500 micrometer in diameter. OCP/Collagen was molded in the shape of a disc, 9 mm diameter, and 1.5 mm thick. Then OCP/Collagen was sterilized using electron beam irradiation at 15kGy. The protocol of the clinical trial was submitted and approved by the research ethics commitee of the Tohoku University Graduate School of Dentistry. In this study, we performed sinus floor elevation in a 41-years old man at left sinus under local anesthesia. 19 OCP/Collagen discs (approximately 1.8 cc) were used in this surgery. We observed the healing at operative region and confirmed having infection or allergy, or not and radiographic examination or CT scan was performed at 3 or 6 months after operation. Furthermore, we performed bone biopsy at the same time of placement of dental implant and we examined the newly formed bone historically. Result: There was no abnormality for healing, no infection and no allergic reaction for the entire period. OCP or OCP/Collagen does not have radiopacity under normal X-ray condition. However, radiopacity of OCP/Collagen implanted in sinus increased with time. CT scan showed radiopacity at 3 months after implantation. At 6 months, the radiopacity of that was almost same as surrounding bone of that in cancellous bone. Histological analysis showed the normal bone tissue including a little remaining impants. Discussion: These results showed that OCP/Collagen could convert to bone tissue in clinical use of sinus floor elevation. It was suggested that OCP/Collagen could be a suitable material for bone augmentation.
机译:简介:基于体外和体内研究,合成八氯钙(OCP)被认为是一种高度骨导电骨替代材料。 OCP以剂量依赖性方式在体外增强骨细胞分化。此外,在大鼠临界大小的Calvaria缺损W中的胶原蛋白基质中,在体内植入中,在临床尺寸缺陷W. OCP比BE-TA磷酸钙(BE-TA TCP)中的溶解度更高,因此在体内植入的剂量熵刺激容量比βTCP在体内更像β-TCP更高的溶解度。已经表明,与OCP本身相比,OCP与胶原(OCP /胶原蛋白)相结合促进骨再生。 OCP /胶原的骨导电性也已经证明了狗的临界骨缺陷。之后,我们检查了OCP /胶原蛋白对人体小骨缺损中骨再生的影响,并证实了缺陷的愈合。在这项研究中,我们对OCP /胶原蛋白进行了骨骼增强的骨骼抬高作为临床患者牙科植入物治疗的制备。实验方法:通过混合NAD磷酸钙溶液,根据合成方法制备OCP。 OCP的粒度直径为300-500微米。 OCP /胶原块以盘,9mm直径和1.5mm厚的形状模塑。然后在15 kgy下使用电子束照射灭菌OCP /胶原蛋白。临床试验的议定书被Tohohu大学牙科研究生院的研究伦理委员会提交和批准。在这项研究中,我们在局部麻醉下的左窦的41岁男性中进行了鼻落楼梯。在这种手术中使用了19个OCP /胶原蛋白(约1.8cc)。我们观察到术治疗区域的愈合,并确认感染或过敏,或没有放射线检查或CT扫描在操作后3或6个月进行。此外,我们在牙科植入物的同时进行骨骼活检,我们历来检查了新形成的骨骼。结果:治疗没有异常,无感染,整个时期没有过敏反应。 OCP或OCP /胶原蛋白在正常X射线条件下没有辐射空缺性。然而,植入鼻窦的OCP /胶原蛋白的辐射缺失性随时间而增加。 CT扫描在植入后3个月显示辐射缺失性。在6个月时,辐射覆盖物几乎与松质骨骼的周围骨骼相同。组织学分析显示正常的骨组织,包括少量杂散。讨论:这些结果表明,OCP /胶原蛋白可转化为鼻窦地板高度的临床使用中的骨组织。建议OCP /胶原蛋白可以是骨骼增强的合适材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号